Tuesday, December 18, 2018 11:38:10 AM
Recent RSLS News
- ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System • GlobeNewswire Inc. • 03/28/2024 12:31:00 PM
- ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX • GlobeNewswire Inc. • 03/04/2024 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:19:43 PM
- ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX • GlobeNewswire Inc. • 02/22/2024 01:31:00 PM
- ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX • GlobeNewswire Inc. • 01/24/2024 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:38:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 11:11:06 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/05/2024 09:14:25 PM
- ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives • GlobeNewswire Inc. • 12/20/2023 01:31:00 PM
- ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX • GlobeNewswire Inc. • 12/12/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:05:16 PM
- ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds • GlobeNewswire Inc. • 11/21/2023 01:06:14 PM
- ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update • GlobeNewswire Inc. • 11/06/2023 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:42:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 08:05:13 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 10/03/2023 01:23:13 PM
- ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering • GlobeNewswire Inc. • 09/29/2023 04:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/27/2023 09:30:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:02:52 PM
- ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI • GlobeNewswire Inc. • 09/22/2023 12:31:00 PM
- ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System • GlobeNewswire Inc. • 09/21/2023 12:31:00 PM
- ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System • GlobeNewswire Inc. • 09/19/2023 12:31:00 PM
- ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device • GlobeNewswire Inc. • 09/14/2023 12:31:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM